DR. ALICIA MARLENE HURTADO, M.D.
Psychiatric at Gustave L Levy Pl, New York, NY
License number
New York 246727
Category
Psychiatric
Type
Psychiatry
Address
Address
1 Gustave L Levy Pl, New York, NY 10029
Phone
(212) 659-9100
Personal information
See more information about ALICIA MARLENE HURTADO at radaris.comName
Address
Phone
503 W 111Th St, New York, NY 10025
1834 Hering Ave, Bronx, NY 10461
30 Waterside Plz APT 26E, New York, NY 10010
11 Hillside Ave, New York, NY 10040
1713 Madison St, Ridgewood, NY 11385
Professional information
See more information about ALICIA MARLENE HURTADO at trustoria.com
Alicia Marlene Hurtado, New York NY
Alicia Marlene Hurtado, New York NY
Specialties:
Psychiatrist
Address:
1 Gustave L Levy Pl, New York, NY 10029
Board certifications:
American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology)
Dr. Alicia M Hurtado, New York NY - MD (Doctor of Medicine)
Dr. Alicia M Hurtado, New York NY - MD (Doctor of Medicine)
Specialties:
Psychiatry
Address:
345 E 102Nd St SUITE 229, New York 10029
MOUNT SINAI SCHOOL OF MEDICINE
1 Gustave L Levy Pl SUITE 1230, New York 10029
(212) 241-6500 (Phone), (212) 987-4031 (Fax)
MOUNT SINAI SCHOOL OF MEDICINE
1 Gustave L Levy Pl SUITE 1230, New York 10029
(212) 241-6500 (Phone), (212) 987-4031 (Fax)
Certifications:
Psychiatry, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Mt Sinai Sch Of Med Of Ny Univ
Graduated: 2004
Mt Sinai Sch Of Med Of Ny Univ
Graduated: 2004
Defective Sindbis Viral Vectors
Defective Sindbis Viral Vectors
US Patent:
2007002, Jan 25, 2007
Filed:
Mar 28, 2006
Appl. No.:
11/392926
Inventors:
Alicia Hurtado - New York NY, US
Daniel Meruelo - Scarborough NY, US
Daniel Meruelo - Scarborough NY, US
Assignee:
New York University - New York NY
International Classification:
A61K 48/00, C12N 15/86
US Classification:
424093200, 435456000, 977802000
Abstract:
Disclosed herein are new defective Sindbis viral vectors made from wild type Ar-339 Sindbis virus, with differences in replicase and envelope proteins between JT vectors and consensus Sindbis virus sequences, and also between JT and Ar-339 vectors. Also disclosed are plasmids used for the production of the vectors, methods for producing the vectors, methods for treating mammals suffering from tumors and pharmaceutical formulations for use in the treatment methods.
Defective Sindbis Viral Vector Comprising An Anti-Tumor Gene
Defective Sindbis Viral Vector Comprising An Anti-Tumor Gene
US Patent:
8530232, Sep 10, 2013
Filed:
Oct 23, 2007
Appl. No.:
11/877018
Inventors:
Alicia Hurtado - New York NY, US
Daniel Meruelo - Scarborough NY, US
Daniel Meruelo - Scarborough NY, US
Assignee:
New York University - New York NY
International Classification:
C12N 15/00
US Classification:
4353201, 435455
Abstract:
Disclosed herein are new defective Sindbis viral vectors made from wild type Ar-339 Sindbis virus, with differences in replicase and envelope proteins between JT vectors and consensus Sindbis virus sequences, and also between JT and Ar-339 vectors. Also disclosed are plasmids used for the production of the vectors, methods for producing the vectors, methods for treating mammals suffering from tumors and pharmaceutical formulations for use in the treatment methods.
Defective Sindbis Viral Vectors
Defective Sindbis Viral Vectors
US Patent:
8093021, Jan 10, 2012
Filed:
Jun 15, 2009
Appl. No.:
12/484818
Inventors:
Alicia Hurtado - New York NY, US
Daniel Meruelo - Scarborough NY, US
Daniel Meruelo - Scarborough NY, US
Assignee:
New York University - New York NY
International Classification:
C12N 15/64, C12N 15/00, C07H 21/02, C07H 21/04
US Classification:
435 914, 4353201, 536 231
Abstract:
Disclosed herein are new defective Sindbis viral vectors made from a novel Helper plasmid, with differences in envelope proteins between JT vectors and consensus Sindbis virus sequences, and also between JT and Ar-339 vectors. Also disclosed are vectors produced using the plasmid, methods for producing the vectors, methods for treating mammals suffering from tumors and pharmaceutical formulations for use in the treatment methods.
Defective Sindbis Viral Vectors
Defective Sindbis Viral Vectors
US Patent:
2008030, Dec 4, 2008
Filed:
May 20, 2008
Appl. No.:
12/123790
Inventors:
Alicia Hurtado - New York NY, US
Daniel Meruelo - Scarborough NY, US
Daniel Meruelo - Scarborough NY, US
Assignee:
New York University - New York NY
International Classification:
C07H 21/00
US Classification:
536 231
Abstract:
Disclosed herein are new defective Sindbis viral vectors made from wild type Ar-339 Sindbis virus, with differences in replicase and envelope proteins between JT vectors and consensus Sindbis virus sequences, and also between JT and Ar-339 vectors. Also disclosed are plasmids used for the production of the vectors, methods for producing the vectors, methods for treating mammals suffering from tumors and pharmaceutical formulations for use in the treatment methods.
Defective Sindbis Viral Vectors
Defective Sindbis Viral Vectors
US Patent:
2008016, Jul 3, 2008
Filed:
Oct 22, 2007
Appl. No.:
11/876522
Inventors:
Alicia Hurtado - New York NY, US
Daniel Meruelo - Scarborough NY, US
Daniel Meruelo - Scarborough NY, US
Assignee:
New York University - New York NY
International Classification:
A61K 31/70, C12N 15/00
US Classification:
514 44, 4353201
Abstract:
Disclosed herein are new defective Sindbis viral vectors made from wild type Ar-339 Sindbis virus, with differences in replicase and envelope proteins between JT vectors and consensus Sindbis virus sequences, and also between JT and Ar-339 vectors. Also disclosed are plasmids used for the production of the vectors, methods for producing the vectors, methods for treating mammals suffering from tumors and pharmaceutical formulations for use in the treatment methods.